Literature DB >> 1309617

Immunoblots with rhodopsin antisera suggest that a purified mu opioid binding protein has structural characteristics of a G-protein-coupled receptor.

T L Gioannini1, E R Weiss, G L Johnson, J M Hiller, E J Simon.   

Abstract

A mu opioid binding protein (OBP), previously purified to homogeneity from bovine striatal membranes, was examined by immunoblotting with six antisera against bovine rhodopsin. An antibody against the carboxyl-terminal tail of rhodopsin and one against membrane-associated rhodopsin gave strong signals at the appropriate molecular mass (65 kDa). An antibody directed against the first cytoplasmic loop of rhodopsin was weakly reactive. Three other antibodies did not recognize OBP. This pattern of crossreactivity was identical to that previously seen with beta-adrenergic receptors. The existence of domains in the OBP, which are antigenically similar to those in two other guanine nucleotide regulatory protein-coupled receptors, supports the hypothesis that mu opioid receptors have the structure characteristic of this receptor family.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309617      PMCID: PMC48173          DOI: 10.1073/pnas.89.1.52

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Kappa-opiate agonists inhibit adenylate cyclase and produce heterologous desensitization in rat spinal cord.

Authors:  B Attali; D Saya; Z Vogel
Journal:  J Neurochem       Date:  1989-02       Impact factor: 5.372

2.  Site-directed mutagenesis of the cytoplasmic domains of the human beta 2-adrenergic receptor. Localization of regions involved in G protein-receptor coupling.

Authors:  B F O'Dowd; M Hnatowich; J W Regan; W M Leader; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1988-11-05       Impact factor: 5.157

3.  Mu and delta opiate receptors coupled negatively to adenylate cyclase on embryonic neurons from the mouse striatum in primary cultures.

Authors:  H Chneiweiss; J Glowinski; J Premont
Journal:  J Neurosci       Date:  1988-09       Impact factor: 6.167

4.  Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor.

Authors:  B K Kobilka; H Matsui; T S Kobilka; T L Yang-Feng; U Francke; M G Caron; R J Lefkowitz; J W Regan
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

5.  Mutations that uncouple the beta-adrenergic receptor from Gs and increase agonist affinity.

Authors:  C D Strader; R A Dixon; A H Cheung; M R Candelore; A D Blake; I S Sigal
Journal:  J Biol Chem       Date:  1987-12-05       Impact factor: 5.157

Review 6.  Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity.

Authors:  B K Kobilka; T S Kobilka; K Daniel; J W Regan; M G Caron; R J Lefkowitz
Journal:  Science       Date:  1988-06-03       Impact factor: 47.728

7.  Identification and sequence of a binding site peptide of the beta 2-adrenergic receptor.

Authors:  H G Dohlman; M G Caron; C D Strader; N Amlaiky; R J Lefkowitz
Journal:  Biochemistry       Date:  1988-03-22       Impact factor: 3.162

8.  Covalent labeling of opioid receptors with radioiodinated human beta-endorphin. Identification of binding site subunit.

Authors:  A D Howard; S de La Baume; T L Gioannini; J M Hiller; E J Simon
Journal:  J Biol Chem       Date:  1985-09-05       Impact factor: 5.157

9.  The GTP-binding protein, Go, regulates neuronal calcium channels.

Authors:  J Hescheler; W Rosenthal; W Trautwein; G Schultz
Journal:  Nature       Date:  1987 Jan 29-Feb 4       Impact factor: 49.962

10.  Purification of bovine striatal dopamine D-2 receptor by affinity chromatography.

Authors:  J Ramwani; R K Mishra
Journal:  J Biol Chem       Date:  1986-07-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.